Cochrane Review on primaquine to prevent malaria transmission

Independent review of the effects of adding a single dose of primaquine to malaria treatment to prevent the transmission of the disease

2014-07-03

(Press-News.org) Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, conducted an independent review of the effects of adding a single dose of primaquine (PQ) to malaria treatment to prevent the transmission of the disease. Mosquitoes become infected with Plasmodium falciparum when they ingest gametocyte-stage parasites from an infected person's blood. PQ is an antimalarial drug that does not cure malaria illness, but is known to kill the gametocyte stage of the P falciparum parasite, thus potentially limiting transmission to further humans. PQ is known to have potentially serious side effects for those who have the glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency, which is common in many malaria endemic regions. In 2012 the World Health Organization (WHO) revised its recommendation for a single dose of PQ alongside treatment for P. falciparum malaria from 0.75 mg/kg down to 0.25mg/kg due to concerns about safety. The three authors looked at a total of 18 trials to examine the evidence of benefits and harms of using PQ in this way by evaluating whether PQ will reduce malaria transmission or the potential that it will reduce transmission based on infectious stages (gametocytes) in the blood. This fresh analysis grouped the studies by dose, to evaluate the effects of the low dose currently recommended by the WHO. None of the included studies tested whether PQ added to malaria treatment reduced the community transmission intensity of malaria. Two studies showed that PQ at doses of 0.75 mg/kg reduced the number of mosquitoes infected after biting humans. PQ does reduce the proportion of people with gametocyte stages, the numbers of gametocytes and the duration of infectiousness (the period that gametocytes are detected in the blood) at doses of 0.4 mg/kg or above, but two trials at lower doses showed no effect. Patricia Graves, from James Cook University in Cairns, said: "Evidence shows that at PQ doses of 0.4 mg/kg and above there is reduction in infectiousness of individuals. Whether this translates into an effect at community level in reducing transmission is not clear. Given the lack of safety data in those with G6PD deficiency, the data do not reveal whether the revised dosing recommendation will have a positive impact on health." INFORMATION: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008152.pub3/abstract

ELSE PRESS RELEASES FROM THIS DATE:

More left-handed men are born during the winter

2014-07-03

Various manual tasks in everyday life require the use of the right hand or are optimized for right-handers. Around 90 percent of the general population is right-handed, only about 10 percent is left-handed. The study of Ulrich Tran, Stefan Stieger, and Martin Voracek comprised two large and independent samples of nearly 13000 adults from Austria and Germany. As in modern genetic studies, where a discovery-and-replication-sample design is standard, the use of two samples allowed testing the replicability and robustness of findings within one-and-the-same study. Overall, ...

Power consumption of robot joints could be 40 perecnt less, according to a laboratory study

2014-07-03

Let us imagine, for a moment, the arm of a robot that lifts a cup of coffee to its "lips" over and over again. The joint of this robotic arm needs a certain flexibility plus an electric motor to drive the upward and downward movements. So orders have to be sent to the motor so that the joint can perform the corresponding movements. "The motors need to receive orders constantly. In fact, the motor has to know at all times what angle its axis has to be at. However, current digital controllers only issue orders at specific moments (in discrete time); they can be described ...

Purdue-designed tool helps guide brain cancer surgery

2014-07-03

WEST LAFAYETTE, Ind. — A tool to help brain surgeons test and more precisely remove cancerous tissue was successfully used during surgery, according to a Purdue University and Brigham and Women's Hospital study. The Purdue-designed tool sprays a microscopic stream of charged solvent onto the tissue surface to gather information about its molecular makeup and produces a color-coded image that reveals the location, nature and concentration of tumor cells. "In a matter of seconds this technique offers molecular information that can detect residual tumor that otherwise ...

New insights into the treatment of children and youth exposed to acts of terror

2014-07-03

In a cluster of articles released today in the peer reviewed European Journal of Psychotraumatology, researchers provide new insights into the treatment of children and youth exposed to acts of terror. The work is drawn from studies examining the mass shooting at Utoya, Norway in 2011, and two school shootings in Finland – Jokela in 2007 and Kauhajoki in 2008. A lead researcher in the cluster is noted Norwegian child psychiatrist and terror expert Dr. Grete Dyb of the University of Oslo and the Norwegian Center for Violence and Traumatic Stress Studies. "Terror ...

How you cope with stress may increase your risk for insomnia

2014-07-03

DARIEN, IL – A new study is the first to identify specific coping behaviors through which stress exposure leads to the development of insomnia. Results show that coping with a stressful event through behavioral disengagement – giving up on dealing with the stress – or by using alcohol or drugs each significantly mediated the relationship between stress exposure and insomnia development. Surprisingly, the coping technique of self-distraction – such as going to the movies or watching TV – also was a significant mediator between stress and incident insomnia. Furthermore, ...

Penn Research lends new insights on conditions for new blood vessel formation

2014-07-03

Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is essential to the body's development. As organs grow, vascular networks must grow with them to feed new cells and remove their waste. The same process, however, also plays a critical role in the onset and progression of many cancers, as it allows the rapid growth of tumors. With lifesaving applications possible in both inhibiting and accelerating the creation of new blood vessels, a more fundamental understanding of what regulates angiogenesis is needed. Now, researchers at the University of Pennsylvania, ...

One third of dyslexic adults report being physically abused during childhood

2014-07-03

Adults who have dyslexia are much more likely to report they were physically abused before they turned 18 than their peers without dyslexia, according to a new study from researchers at the University of Toronto and the University of North Carolina School of Medicine in Chapel Hill. Thirty-five per cent of adults with dyslexia report they were physically abused before they turned 18. In contrast, seven per cent of those without dyslexia reported that they had experienced childhood physical abuse. "Even after accounting for age, race, sex and other early adversities ...

WHO targets elimination of TB in over 30 countries

2014-07-03

3 JULY 2014 | ROME, ITALY - The World Health Organization (WHO) today, together with the European Respiratory Society (ERS), presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33* countries and territories where there are fewer than 100 TB cases per million population. The framework outlines an initial "pre-elimination" phase, aiming to have fewer than 10 new TB cases per million people per year by 2035 in these countries. The goal is to then achieve full elimination of TB by 2050, defined as less than ...

New study discovers biological basis for magic mushroom 'mind expansion'

2014-07-03

New research shows that our brain displays a similar pattern of activity during dreams as it does during a mind-expanding drug trip. Psychedelic drugs such as LSD and magic mushrooms can profoundly alter the way we experience the world but little is known about what physically happens in the brain. New research, published in Human Brain Mapping, has examined the brain effects of the psychedelic chemical in magic mushrooms, called 'psilocybin,' using data from brain scans of volunteers who had been injected with the drug. The study found that under psilocybin, activity ...

Cleveland Clinic researchers identify urgent need for Alzheimer's drug development

2014-07-03

THURSDAY, July 3, 2014, Las Vegas: Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. The paper, "Alzheimer's Disease Drug Development Pipeline: Few Candidates, Frequent Failures," was published today in the journal Alzheimer's Research & Therapy. A comprehensive look at all clinical trials underway shows: There ...

Cochrane Review on primaquine to prevent malaria transmission

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: